The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
Open accessAbstract
[This corrects the article DOI: 10.1371/journal.pone.0054193.].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
Clonogenic assay of cells in vitro
Franken, N. A. P., Rodermond, H. M., Stap, J., Haveman, J., & van Bree, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.339 · Cited by 4,188
Identification and expansion of the tumorigenic lung cancer stem cell population
Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., & De Maria, R. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402283 · Cited by 1,707
Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells
Masui, S., Nakatake, Y., Toyooka, Y., Shimosato, D., Yagi, R., Takahashi, K., Okochi, H., Okuda, A., Matoba, R., Sharov, A. A., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1589 · Cited by 1,252
Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8493 · Cited by 858
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Jiang, F., Qiu, Q., Khanna, A., Todd, N. W., Deepak, J., Xing, L., Wang, H., Liu, Z., Su, Y., Stass, S. A., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0393 · Cited by 788
Bertolini, G., Roz, L., Perego, P., Tortoreto, M., Fontanella, E., Gatti, L., Pratesi, G., Fabbri, A., Andriani, F., Tinelli, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905653106 · Cited by 767
Cisplatin and platinum drugs at the molecular level (Review)
Boulikas, T., & Vougiouka, M. (2003) · Oncology Reports · doi:10.3892/or.10.6.1663 · Cited by 729
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1034 · Cited by 588
Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
Chen, Y.-C., Hsu, H.-S., Chen, Y.-W., Tsai, T.-H., How, C.-K., Wang, C.-Y., Hung, S.-C., Chang, Y.-L., Tsai, M.-L., Lee, Y.-Y., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002637 · Cited by 508
Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties
Leung, E. L.-H., Fiscus, R. R., Tung, J. W., Tin, V. P.-C., Cheng, L. C., Sihoe, A. D.-L., Fink, L. M., Ma, Y., & Wong, M. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014062 · Cited by 473
Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by Cisplatin
Sorenson, C. M., Barry, M. A., & Eastman, A. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.9.749 · Cited by 443
Furuta, T., Ueda, T., Aune, G. J., Sarasin, A. R., Kraemer, K. H., & Pommier, Y. G. (2002) · PubMed · Cited by 422
Cisplatin (cis-diamminedichloroplatinum II)
Prestayko, A. W., D'Aoust, J. C., Issell, B. F., & Crooke, S. T. (1979) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(79)80057-2 · Cited by 405
Bunn, P. A., & Kelly, K. L. (1998) · PubMed · Cited by 400
Clinical Perspectives on Platinum Resistance
Giaccone, G. (2000) · Drugs · doi:10.2165/00003495-200059004-00002 · Cited by 364
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Y., & Wu, P. Y. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0338 · Cited by 293
Katano, K., Kondo, A., Safaei, R., Holzer, A. K., Samimi, G., Mishima, M., Kuo, Y., Rochdi, M., & Howell, S. B. (2002) · PubMed · Cited by 291
Preclinical Perspectives on Platinum Resistance
Kelland, L. R. (2000) · Drugs · doi:10.2165/00003495-200059004-00001 · Cited by 280
Giaccone, G., Splinter, T. A., Debruyne, C., Kho, G. S., Lianes, P., van Zandwijk, N., Pennucci, M. C., Scagliotti, G., van Meerbeeck, J., van Hoesel, Q., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2133 · Cited by 275
McDonald, E. S., Randon, K. R., Knight, A., & Windebank, A. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.013 · Cited by 227
Tirino, V., Camerlingo, R., Franco, R., Malanga, D., La Rocca, A., Viglietto, G., Rocco, G., & Pirozzi, G. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2009.03.063 · Cited by 213
Sullivan, J. P., Minna, J. D., & Shay, J. W. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9216-5 · Cited by 176
Chen, S., Xu, Y., Chen, Y., Li, X., Mou, W., Wang, L., Liu, Y., Reisfeld, R. A., Xiang, R., Lv, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036326 · Cited by 160
Samimi, G., Katano, K., Holzer, A. K., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.25 · Cited by 158
Identification of uPAR-positive Chemoresistant Cells in Small Cell Lung Cancer
Gutova, M., Najbauer, J., Gevorgyan, A., Metz, M. Z., Weng, Y., Shih, C.-C., & Aboody, K. S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000243 · Cited by 141
Liedert, B., Materna, V., Schadendorf, D., Thomale, J., & Lage, H. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12313.x · Cited by 129
Self-citationCisplatin/carboplatin cross-resistance in ovarian cancer
Gore, M. E., Fryatt, I., Wiltshaw, E., Dawson, T., Robinson, B. A., & Calvert, H. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.356 · Cited by 116
Liedert, B. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl051 · Cited by 115
Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance.
Vasey, P. A., Jones, N. A., Jenkins, S., Dive, C., & Brown, R. E. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09612-9 · Cited by 110
Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
Stuelten, C. H., Mertins, S. D., Busch, J. I., Theofiles, M., Scudiero, D. A., Burkett, M. W., Hite, K. M., Alley, M., Hollingshead, M. G., Shoemaker, R. H., et al. (2010) · Stem Cells · doi:10.1002/stem.324 · Cited by 105
Moreb, J. S., Schweder, M., Suresh, A., & Zucali, J. R. (1996) · PubMed · Cited by 84
Twentyman, P. R. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90452-4 · Cited by 78
Separating Stem Cells by Flow Cytometry: Reducing Variability for Solid Tissues
Alexander, C. M., Puchalski, J. R., Klos, K. S., Badders, N. M., Ailles, L., Kim, C. F., Dirks, P. B., & Smalley, M. J. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.11.008 · Cited by 70
Ovarian cancer: new clinical approaches
Ozols, R. F. (1991) · Cancer Treatment Reviews · doi:10.1016/0305-7372(91)90027-w · Cited by 67
Sreerama, L., & Sládek, N. E. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5871-2_11 · Cited by 49
Role of metallothionein in cisplatin sensitivity of germ-cell tumours
Meijer, C., Timmer, A., de Vries, E. G. E., Groten, J. P., Knol, A., Zwart, N., Dam, W., Sleijfer, D. T., & Mulder, N. H. (2000) · International Journal of Cancer · Cited by 47
Patnaik, S. K., Kannisto, E. D., Mallick, R., & Yendamuri, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022379 · Cited by 44
Crawford, N., Chacko, A. D., Savage, K. I., McCoy, F. P. G., Redmond, K. M., Longley, D. B., & Fennell, D. A. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0561-1 · Cited by 29
Self-citationPlace of Parenteral Cephalosporins in the Ambulatory Setting: Clinical Evidence
Nathwani, D. (2000) · Drugs · doi:10.2165/00003495-200059003-00005 · Cited by 28
Chemotherapy for Advanced Epithelial Ovarian Cancer
Ozols, R. F. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30316-2 · Cited by 27
Wang, J., Wang, H., Zhao, L., Fan, S., Yang, Z., Gao, F., Chen, L., Xiao, G. G., Molnar, J. A., & Wang, Q. (2010) · PubMed · Cited by 23
Sekiguchi, I., Suzuki, M., Tamada, T., Shinomiya, N., TSURU, S., & MURATA, M. (2009) · Oncology · doi:10.1159/000227529 · Cited by 21
Barr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054193 · Cited by 19
Self-citation
Cited by
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Testa, U., Castelli, G., & Pelosi, E. (2018) · Cancers · doi:10.3390/cancers10080248 · Cited by 403
Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
Fennell, D. A., Summers, Y., Cadranel, J., Benepal, T., Christoph, D. C., Lal, R., Das, M., Maxwell, F., Visseren-Grul, C., & Ferry, D. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.01.003 · Cited by 382
Self-citationMcDermott, M., Eustace, A. J., Busschots, S., Breen, L., Crown, J., Clynes, M., O’Donovan, N., & Stordal, B. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00040 · Cited by 315
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Godwin, P., Baird, A. M., Heavey, S., Barr, M. P., O’Byrne, K. J., & Gately, K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00120 · Cited by 296
Self-citationRole of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D. (2020) · BioMed Research International · doi:10.1155/2020/9390878 · Cited by 131
Metadata
- Authors
- Barr, M. P., Gray, S. G., Hoffmann, A. C., Hilger, R. A., Thomale, J., O’Flaherty, J. D., Fennell, D. A., Richard, D., O’Leary, J. J., & O’Byrne, K. J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-05-21
- Volume
- 15
- Issue
- 5
- Pages
- e0233739
- ISSN
- 1932-6203
- OpenAlex
- W2058845478
- Cited by
- 269
- References
- 48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.